ENTITY
Regulus Therapeutics

Regulus Therapeutics (RGLS US)

2
Analysis
Health CareUnited States
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat and prevent hepatitis C infections, cardiovascular, fibrosis, oncology, immuno-inflammatory, and metabolic diseases. Regulas Therapeutics offers its services worldwide.
more
Company Event29 Aug 2025 04:00 • Upcoming
Add To Calendar
Company Event09 May 2025 04:00 • Upcoming
Add To Calendar
Company Event14 Mar 2025 04:00 • Upcoming
Add To Calendar
Company Event12 Mar 2025 03:40 • Latest
x